These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 38425695)
1. Positron emission tomography and its role in the assessment of vulnerable plaques in comparison to other imaging modalities. Proaño-Bernal L; Gilabert-García A; Sharma-Sharma S; Mora-Barrera CM; Singer-De-la-Garza J; Beristain-de-la-Rosa PY; Basile-Alvarez MR; Guerra EC; Bermudez-Gonzalez JL; Luna-Alcala S; Espinola-Zavaleta N; Alexanderson-Rosas E Front Med (Lausanne); 2023; 10():1293848. PubMed ID: 38425695 [TBL] [Abstract][Full Text] [Related]
2. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque. Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390 [TBL] [Abstract][Full Text] [Related]
3. Salt in the wound: (18)F-fluoride positron emission tomography for identification of vulnerable coronary plaques. Adamson PD; Vesey AT; Joshi NV; Newby DE; Dweck MR Cardiovasc Diagn Ther; 2015 Apr; 5(2):150-5. PubMed ID: 25984456 [TBL] [Abstract][Full Text] [Related]
4. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging. Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367 [TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392 [TBL] [Abstract][Full Text] [Related]
6. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results. Quirce R; Martínez-Rodríguez I; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; López-Defilló J; Jiménez-Alonso M; Revilla MA; Carril JM Clin Physiol Funct Imaging; 2016 Nov; 36(6):499-503. PubMed ID: 26147617 [TBL] [Abstract][Full Text] [Related]
7. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study. Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136 [TBL] [Abstract][Full Text] [Related]
8. The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. Calcagno C; Ramachandran S; Izquierdo-Garcia D; Mani V; Millon A; Rosenbaum D; Tawakol A; Woodward M; Bucerius J; Moshier E; Godbold J; Kallend D; Farkouh ME; Fuster V; Rudd JH; Fayad ZA Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1884-93. PubMed ID: 23942908 [TBL] [Abstract][Full Text] [Related]
9. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186 [TBL] [Abstract][Full Text] [Related]
10. Non-calcified active atherosclerosis plaque detection with 18F-NaF and 18F-FDG PET/CT dynamic imaging. Douhi A; Al-Enezi MS; Berrahmoune N; Khalil A; Fulop T; Nguyen M; Turcotte E; Croteau É; Bentourkia M Phys Eng Sci Med; 2023 Mar; 46(1):295-302. PubMed ID: 36715851 [TBL] [Abstract][Full Text] [Related]
11. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose. Chen W; Dilsizian V Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466 [TBL] [Abstract][Full Text] [Related]
12. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Joshi NV; Vesey AT; Williams MC; Shah AS; Calvert PA; Craighead FH; Yeoh SE; Wallace W; Salter D; Fletcher AM; van Beek EJ; Flapan AD; Uren NG; Behan MW; Cruden NL; Mills NL; Fox KA; Rudd JH; Dweck MR; Newby DE Lancet; 2014 Feb; 383(9918):705-13. PubMed ID: 24224999 [TBL] [Abstract][Full Text] [Related]
13. A longitudinal Zhuang X; Feng Y; Li J; Zhao F; Zhang Y; Chen Y Cardiovasc Diagn Ther; 2021 Feb; 11(1):39-49. PubMed ID: 33708476 [TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]